nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CYP2D6—Lomustine—brain cancer	0.0611	0.253	CbGbCtD
Aripiprazole—CYP2D6—Hydroxyurea—brain cancer	0.0463	0.192	CbGbCtD
Aripiprazole—CYP3A4—Temozolomide—brain cancer	0.0457	0.19	CbGbCtD
Aripiprazole—CYP3A4—Lomustine—brain cancer	0.0388	0.161	CbGbCtD
Aripiprazole—CYP3A5—Etoposide—brain cancer	0.0241	0.0999	CbGbCtD
Aripiprazole—ABCB1—Etoposide—brain cancer	0.0157	0.065	CbGbCtD
Aripiprazole—CYP3A4—Etoposide—brain cancer	0.00939	0.0389	CbGbCtD
Aripiprazole—HTR1D—cranial nerve—brain cancer	0.00369	0.0134	CbGeAlD
Aripiprazole—HTR6—ganglion—brain cancer	0.0032	0.0116	CbGeAlD
Aripiprazole—DRD5—ganglion—brain cancer	0.00311	0.0113	CbGeAlD
Aripiprazole—HTR1B—telencephalic ventricle—brain cancer	0.0031	0.0112	CbGeAlD
Aripiprazole—HTR1D—telencephalic ventricle—brain cancer	0.003	0.0109	CbGeAlD
Aripiprazole—HTR2C—telencephalic ventricle—brain cancer	0.00297	0.0108	CbGeAlD
Aripiprazole—HTR7—cranial nerve—brain cancer	0.00294	0.0106	CbGeAlD
Aripiprazole—HTR7—pons—brain cancer	0.0029	0.0105	CbGeAlD
Aripiprazole—HTR2A—trigeminal nerve—brain cancer	0.00257	0.00931	CbGeAlD
Aripiprazole—HTR2A—cerebellar cortex—brain cancer	0.00256	0.00927	CbGeAlD
Aripiprazole—HTR1A—telencephalic ventricle—brain cancer	0.0025	0.00905	CbGeAlD
Aripiprazole—HTR7—telencephalic ventricle—brain cancer	0.00239	0.00865	CbGeAlD
Aripiprazole—DRD1—ganglion—brain cancer	0.00238	0.00862	CbGeAlD
Aripiprazole—HTR2A—vein—brain cancer	0.00232	0.00841	CbGeAlD
Aripiprazole—HTR3A—ganglion—brain cancer	0.0023	0.00832	CbGeAlD
Aripiprazole—DRD2—telencephalic ventricle—brain cancer	0.00226	0.00818	CbGeAlD
Aripiprazole—HTR1B—ganglion—brain cancer	0.00193	0.00698	CbGeAlD
Aripiprazole—HTR1D—ganglion—brain cancer	0.00187	0.00676	CbGeAlD
Aripiprazole—HTR2C—ganglion—brain cancer	0.00185	0.00669	CbGeAlD
Aripiprazole—HTR2A—cranial nerve—brain cancer	0.00183	0.00663	CbGeAlD
Aripiprazole—HTR2A—pons—brain cancer	0.00181	0.00656	CbGeAlD
Aripiprazole—HTR1E—brainstem—brain cancer	0.00177	0.00642	CbGeAlD
Aripiprazole—SLC6A4—ganglion—brain cancer	0.00175	0.00635	CbGeAlD
Aripiprazole—HTR1E—telencephalon—brain cancer	0.00157	0.00569	CbGeAlD
Aripiprazole—HTR1A—ganglion—brain cancer	0.00156	0.00563	CbGeAlD
Aripiprazole—HTR1B—blood vessel—brain cancer	0.00153	0.00555	CbGeAlD
Aripiprazole—HTR2A—telencephalic ventricle—brain cancer	0.00149	0.00539	CbGeAlD
Aripiprazole—HTR7—ganglion—brain cancer	0.00149	0.00538	CbGeAlD
Aripiprazole—HTR1D—blood vessel—brain cancer	0.00148	0.00538	CbGeAlD
Aripiprazole—DRD2—ganglion—brain cancer	0.00141	0.00509	CbGeAlD
Aripiprazole—SLC6A4—hindbrain—brain cancer	0.00133	0.00481	CbGeAlD
Aripiprazole—HTR2A—pineal body—brain cancer	0.00129	0.00468	CbGeAlD
Aripiprazole—HTR7—endothelium—brain cancer	0.00128	0.00464	CbGeAlD
Aripiprazole—HTR6—telencephalon—brain cancer	0.00123	0.00447	CbGeAlD
Aripiprazole—DRD5—telencephalon—brain cancer	0.0012	0.00435	CbGeAlD
Aripiprazole—HTR7—blood vessel—brain cancer	0.00118	0.00428	CbGeAlD
Aripiprazole—HTR1A—hindbrain—brain cancer	0.00118	0.00427	CbGeAlD
Aripiprazole—HTR7—hindbrain—brain cancer	0.00113	0.00408	CbGeAlD
Aripiprazole—ADRA1A—hindbrain—brain cancer	0.00109	0.00394	CbGeAlD
Aripiprazole—DRD2—hindbrain—brain cancer	0.00107	0.00386	CbGeAlD
Aripiprazole—DRD1—brainstem—brain cancer	0.00103	0.00375	CbGeAlD
Aripiprazole—HTR3A—brainstem—brain cancer	0.000999	0.00362	CbGeAlD
Aripiprazole—HTR1E—head—brain cancer	0.000979	0.00355	CbGeAlD
Aripiprazole—H1F0—telencephalon—brain cancer	0.000929	0.00337	CbGeAlD
Aripiprazole—HTR2A—ganglion—brain cancer	0.000927	0.00336	CbGeAlD
Aripiprazole—DRD1—telencephalon—brain cancer	0.000918	0.00332	CbGeAlD
Aripiprazole—HTR1E—central nervous system—brain cancer	0.000893	0.00324	CbGeAlD
Aripiprazole—HTR3A—telencephalon—brain cancer	0.000886	0.00321	CbGeAlD
Aripiprazole—CHRM4—head—brain cancer	0.000858	0.00311	CbGeAlD
Aripiprazole—HTR1B—brainstem—brain cancer	0.000838	0.00303	CbGeAlD
Aripiprazole—DRD4—brain—brain cancer	0.000823	0.00298	CbGeAlD
Aripiprazole—HTR1D—brainstem—brain cancer	0.000811	0.00294	CbGeAlD
Aripiprazole—HTR2C—brainstem—brain cancer	0.000803	0.00291	CbGeAlD
Aripiprazole—HTR2A—endothelium—brain cancer	0.000799	0.0029	CbGeAlD
Aripiprazole—DRD3—head—brain cancer	0.000798	0.00289	CbGeAlD
Aripiprazole—CYP3A7—endocrine gland—brain cancer	0.00079	0.00286	CbGeAlD
Aripiprazole—CHRM4—central nervous system—brain cancer	0.000783	0.00284	CbGeAlD
Aripiprazole—H1F0—gonad—brain cancer	0.000775	0.00281	CbGeAlD
Aripiprazole—HTR6—head—brain cancer	0.000768	0.00278	CbGeAlD
Aripiprazole—SLC6A4—brainstem—brain cancer	0.000761	0.00276	CbGeAlD
Aripiprazole—DRD5—endocrine gland—brain cancer	0.000757	0.00274	CbGeAlD
Aripiprazole—H1F0—pituitary gland—brain cancer	0.000757	0.00274	CbGeAlD
Aripiprazole—DRD5—head—brain cancer	0.000748	0.00271	CbGeAlD
Aripiprazole—HTR1B—telencephalon—brain cancer	0.000743	0.00269	CbGeAlD
Aripiprazole—CHRM2—telencephalon—brain cancer	0.000739	0.00268	CbGeAlD
Aripiprazole—HTR2A—blood vessel—brain cancer	0.000737	0.00267	CbGeAlD
Aripiprazole—H1F0—medulla oblongata—brain cancer	0.00073	0.00264	CbGeAlD
Aripiprazole—DRD3—central nervous system—brain cancer	0.000728	0.00264	CbGeAlD
Aripiprazole—HTR1D—telencephalon—brain cancer	0.00072	0.00261	CbGeAlD
Aripiprazole—HTR2C—telencephalon—brain cancer	0.000713	0.00258	CbGeAlD
Aripiprazole—HTR1E—brain—brain cancer	0.000709	0.00257	CbGeAlD
Aripiprazole—HTR2A—hindbrain—brain cancer	0.000703	0.00255	CbGeAlD
Aripiprazole—HTR6—central nervous system—brain cancer	0.000701	0.00254	CbGeAlD
Aripiprazole—ADRB1—telencephalon—brain cancer	0.000699	0.00253	CbGeAlD
Aripiprazole—DRD5—central nervous system—brain cancer	0.000683	0.00247	CbGeAlD
Aripiprazole—HTR1A—brainstem—brain cancer	0.000676	0.00245	CbGeAlD
Aripiprazole—SLC6A4—telencephalon—brain cancer	0.000676	0.00245	CbGeAlD
Aripiprazole—CHRM1—telencephalon—brain cancer	0.000673	0.00244	CbGeAlD
Aripiprazole—CHRM5—head—brain cancer	0.000671	0.00243	CbGeAlD
Aripiprazole—HTR2B—telencephalon—brain cancer	0.00067	0.00243	CbGeAlD
Aripiprazole—H1F0—midbrain—brain cancer	0.000667	0.00242	CbGeAlD
Aripiprazole—DRD1—midbrain—brain cancer	0.000659	0.00239	CbGeAlD
Aripiprazole—H1F0—spinal cord—brain cancer	0.000651	0.00236	CbGeAlD
Aripiprazole—HTR7—brainstem—brain cancer	0.000646	0.00234	CbGeAlD
Aripiprazole—CYP2D6—hindbrain—brain cancer	0.00064	0.00232	CbGeAlD
Aripiprazole—ADRA1A—brainstem—brain cancer	0.000623	0.00226	CbGeAlD
Aripiprazole—CHRM4—brain—brain cancer	0.000622	0.00225	CbGeAlD
Aripiprazole—ADRA1B—head—brain cancer	0.000613	0.00222	CbGeAlD
Aripiprazole—CHRM5—central nervous system—brain cancer	0.000612	0.00222	CbGeAlD
Aripiprazole—DRD2—brainstem—brain cancer	0.000611	0.00221	CbGeAlD
Aripiprazole—CHRM3—telencephalon—brain cancer	0.000602	0.00218	CbGeAlD
Aripiprazole—HTR1A—telencephalon—brain cancer	0.0006	0.00217	CbGeAlD
Aripiprazole—H1F0—endocrine gland—brain cancer	0.000586	0.00212	CbGeAlD
Aripiprazole—H1F0—head—brain cancer	0.000579	0.0021	CbGeAlD
Aripiprazole—DRD3—brain—brain cancer	0.000578	0.00209	CbGeAlD
Aripiprazole—HTR7—telencephalon—brain cancer	0.000573	0.00208	CbGeAlD
Aripiprazole—DRD1—head—brain cancer	0.000571	0.00207	CbGeAlD
Aripiprazole—HTR2C—medulla oblongata—brain cancer	0.00056	0.00203	CbGeAlD
Aripiprazole—ADRA1B—central nervous system—brain cancer	0.00056	0.00203	CbGeAlD
Aripiprazole—HTR6—brain—brain cancer	0.000557	0.00202	CbGeAlD
Aripiprazole—ADRA1A—telencephalon—brain cancer	0.000553	0.002	CbGeAlD
Aripiprazole—HTR3A—head—brain cancer	0.000552	0.002	CbGeAlD
Aripiprazole—DRD2—telencephalon—brain cancer	0.000542	0.00196	CbGeAlD
Aripiprazole—DRD5—brain—brain cancer	0.000542	0.00196	CbGeAlD
Aripiprazole—KCNH2—telencephalon—brain cancer	0.000534	0.00194	CbGeAlD
Aripiprazole—HTR1B—midbrain—brain cancer	0.000534	0.00193	CbGeAlD
Aripiprazole—H1F0—central nervous system—brain cancer	0.000528	0.00191	CbGeAlD
Aripiprazole—ADRA2C—telencephalon—brain cancer	0.000527	0.00191	CbGeAlD
Aripiprazole—DRD1—central nervous system—brain cancer	0.000522	0.00189	CbGeAlD
Aripiprazole—HTR1B—spinal cord—brain cancer	0.000521	0.00189	CbGeAlD
Aripiprazole—HTR1D—midbrain—brain cancer	0.000517	0.00187	CbGeAlD
Aripiprazole—H1F0—cerebellum—brain cancer	0.000516	0.00187	CbGeAlD
Aripiprazole—HTR2C—midbrain—brain cancer	0.000512	0.00185	CbGeAlD
Aripiprazole—HTR3A—central nervous system—brain cancer	0.000504	0.00182	CbGeAlD
Aripiprazole—HTR2C—spinal cord—brain cancer	0.000499	0.00181	CbGeAlD
Aripiprazole—CHRM5—brain—brain cancer	0.000486	0.00176	CbGeAlD
Aripiprazole—SLC6A4—midbrain—brain cancer	0.000485	0.00176	CbGeAlD
Aripiprazole—ABCB1—blood vessel—brain cancer	0.000483	0.00175	CbGeAlD
Aripiprazole—HTR7—gonad—brain cancer	0.000479	0.00173	CbGeAlD
Aripiprazole—SLC6A4—spinal cord—brain cancer	0.000473	0.00172	CbGeAlD
Aripiprazole—HTR1B—endocrine gland—brain cancer	0.000469	0.0017	CbGeAlD
Aripiprazole—CHRM2—endocrine gland—brain cancer	0.000466	0.00169	CbGeAlD
Aripiprazole—HTR1B—head—brain cancer	0.000463	0.00168	CbGeAlD
Aripiprazole—CHRM2—head—brain cancer	0.00046	0.00167	CbGeAlD
Aripiprazole—HTR7—medulla oblongata—brain cancer	0.00045	0.00163	CbGeAlD
Aripiprazole—HTR1D—head—brain cancer	0.000448	0.00162	CbGeAlD
Aripiprazole—ADRA1B—brain—brain cancer	0.000444	0.00161	CbGeAlD
Aripiprazole—HTR2C—head—brain cancer	0.000444	0.00161	CbGeAlD
Aripiprazole—DRD2—pituitary gland—brain cancer	0.000441	0.0016	CbGeAlD
Aripiprazole—ADRB1—endocrine gland—brain cancer	0.000441	0.0016	CbGeAlD
Aripiprazole—ADRB1—head—brain cancer	0.000436	0.00158	CbGeAlD
Aripiprazole—KCNH2—pituitary gland—brain cancer	0.000435	0.00158	CbGeAlD
Aripiprazole—HTR1A—midbrain—brain cancer	0.000431	0.00156	CbGeAlD
Aripiprazole—ADRA2C—pituitary gland—brain cancer	0.000429	0.00155	CbGeAlD
Aripiprazole—HRH1—telencephalon—brain cancer	0.000428	0.00155	CbGeAlD
Aripiprazole—SLC6A4—endocrine gland—brain cancer	0.000426	0.00154	CbGeAlD
Aripiprazole—CHRM1—endocrine gland—brain cancer	0.000425	0.00154	CbGeAlD
Aripiprazole—HTR1B—central nervous system—brain cancer	0.000423	0.00153	CbGeAlD
Aripiprazole—SLC6A4—head—brain cancer	0.000421	0.00152	CbGeAlD
Aripiprazole—ADRA2A—telencephalon—brain cancer	0.000421	0.00152	CbGeAlD
Aripiprazole—HTR1A—spinal cord—brain cancer	0.00042	0.00152	CbGeAlD
Aripiprazole—CHRM2—central nervous system—brain cancer	0.00042	0.00152	CbGeAlD
Aripiprazole—KCNH2—medulla oblongata—brain cancer	0.00042	0.00152	CbGeAlD
Aripiprazole—H1F0—brain—brain cancer	0.000419	0.00152	CbGeAlD
Aripiprazole—CHRM1—head—brain cancer	0.000419	0.00152	CbGeAlD
Aripiprazole—HTR2B—head—brain cancer	0.000417	0.00151	CbGeAlD
Aripiprazole—ADRA2C—medulla oblongata—brain cancer	0.000414	0.0015	CbGeAlD
Aripiprazole—DRD1—brain—brain cancer	0.000414	0.0015	CbGeAlD
Aripiprazole—HTR7—midbrain—brain cancer	0.000412	0.00149	CbGeAlD
Aripiprazole—HTR1D—central nervous system—brain cancer	0.000409	0.00148	CbGeAlD
Aripiprazole—HTR2C—central nervous system—brain cancer	0.000405	0.00147	CbGeAlD
Aripiprazole—HTR2A—brainstem—brain cancer	0.000403	0.00146	CbGeAlD
Aripiprazole—HTR7—spinal cord—brain cancer	0.000402	0.00146	CbGeAlD
Aripiprazole—HTR3A—brain—brain cancer	0.0004	0.00145	CbGeAlD
Aripiprazole—ADRB1—central nervous system—brain cancer	0.000398	0.00144	CbGeAlD
Aripiprazole—DRD2—midbrain—brain cancer	0.000389	0.00141	CbGeAlD
Aripiprazole—SLC6A4—central nervous system—brain cancer	0.000384	0.00139	CbGeAlD
Aripiprazole—KCNH2—midbrain—brain cancer	0.000384	0.00139	CbGeAlD
Aripiprazole—CHRM1—central nervous system—brain cancer	0.000383	0.00139	CbGeAlD
Aripiprazole—HTR2B—central nervous system—brain cancer	0.000381	0.00138	CbGeAlD
Aripiprazole—CHRM3—endocrine gland—brain cancer	0.00038	0.00138	CbGeAlD
Aripiprazole—ADRA2C—midbrain—brain cancer	0.000378	0.00137	CbGeAlD
Aripiprazole—HTR1A—endocrine gland—brain cancer	0.000378	0.00137	CbGeAlD
Aripiprazole—CHRM3—head—brain cancer	0.000375	0.00136	CbGeAlD
Aripiprazole—KCNH2—spinal cord—brain cancer	0.000374	0.00136	CbGeAlD
Aripiprazole—HTR1A—head—brain cancer	0.000374	0.00135	CbGeAlD
Aripiprazole—ADRA2C—spinal cord—brain cancer	0.000369	0.00134	CbGeAlD
Aripiprazole—CYP2D6—brainstem—brain cancer	0.000367	0.00133	CbGeAlD
Aripiprazole—HTR7—endocrine gland—brain cancer	0.000362	0.00131	CbGeAlD
Aripiprazole—HTR2A—telencephalon—brain cancer	0.000358	0.0013	CbGeAlD
Aripiprazole—HTR7—head—brain cancer	0.000357	0.00129	CbGeAlD
Aripiprazole—ADRA2A—gonad—brain cancer	0.000351	0.00127	CbGeAlD
Aripiprazole—ADRA1A—endocrine gland—brain cancer	0.000349	0.00126	CbGeAlD
Aripiprazole—Hypoaesthesia—Carmustine—brain cancer	0.000348	0.00101	CcSEcCtD
Aripiprazole—Decreased appetite—Procarbazine—brain cancer	0.000346	0.00101	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Etoposide—brain cancer	0.000345	0.00101	CcSEcCtD
Aripiprazole—Oedema peripheral—Carmustine—brain cancer	0.000345	0.001	CcSEcCtD
Aripiprazole—ADRA1A—head—brain cancer	0.000344	0.00125	CbGeAlD
Aripiprazole—Connective tissue disorder—Carmustine—brain cancer	0.000344	0.001	CcSEcCtD
Aripiprazole—Fatigue—Procarbazine—brain cancer	0.000343	0.000998	CcSEcCtD
Aripiprazole—ADRA2A—pituitary gland—brain cancer	0.000342	0.00124	CbGeAlD
Aripiprazole—CHRM3—central nervous system—brain cancer	0.000342	0.00124	CbGeAlD
Aripiprazole—DRD2—endocrine gland—brain cancer	0.000342	0.00124	CbGeAlD
Aripiprazole—HTR1A—central nervous system—brain cancer	0.000341	0.00124	CbGeAlD
Aripiprazole—Haemoglobin—Temozolomide—brain cancer	0.00034	0.00099	CcSEcCtD
Aripiprazole—Malaise—Hydroxyurea—brain cancer	0.00034	0.00099	CcSEcCtD
Aripiprazole—Pain—Procarbazine—brain cancer	0.00034	0.00099	CcSEcCtD
Aripiprazole—Constipation—Procarbazine—brain cancer	0.00034	0.00099	CcSEcCtD
Aripiprazole—Hepatitis—Temozolomide—brain cancer	0.000338	0.000985	CcSEcCtD
Aripiprazole—Haemorrhage—Temozolomide—brain cancer	0.000338	0.000985	CcSEcCtD
Aripiprazole—Dysphagia—Etoposide—brain cancer	0.000338	0.000985	CcSEcCtD
Aripiprazole—DRD2—head—brain cancer	0.000338	0.00122	CbGeAlD
Aripiprazole—Leukopenia—Hydroxyurea—brain cancer	0.000338	0.000983	CcSEcCtD
Aripiprazole—Visual impairment—Carmustine—brain cancer	0.000337	0.000983	CcSEcCtD
Aripiprazole—KCNH2—endocrine gland—brain cancer	0.000337	0.00122	CbGeAlD
Aripiprazole—Hallucination—Temozolomide—brain cancer	0.000337	0.00098	CcSEcCtD
Aripiprazole—Hypoaesthesia—Temozolomide—brain cancer	0.000337	0.00098	CcSEcCtD
Aripiprazole—Pharyngitis—Temozolomide—brain cancer	0.000336	0.000978	CcSEcCtD
Aripiprazole—HTR1B—brain—brain cancer	0.000335	0.00122	CbGeAlD
Aripiprazole—Urinary tract disorder—Temozolomide—brain cancer	0.000334	0.000973	CcSEcCtD
Aripiprazole—CHRM2—brain—brain cancer	0.000334	0.00121	CbGeAlD
Aripiprazole—Oedema peripheral—Temozolomide—brain cancer	0.000333	0.000971	CcSEcCtD
Aripiprazole—HTR1A—cerebellum—brain cancer	0.000333	0.00121	CbGeAlD
Aripiprazole—KCNH2—head—brain cancer	0.000333	0.0012	CbGeAlD
Aripiprazole—Connective tissue disorder—Temozolomide—brain cancer	0.000333	0.000968	CcSEcCtD
Aripiprazole—Urethral disorder—Temozolomide—brain cancer	0.000332	0.000966	CcSEcCtD
Aripiprazole—ADRA2A—medulla oblongata—brain cancer	0.00033	0.0012	CbGeAlD
Aripiprazole—ADRA2C—head—brain cancer	0.000328	0.00119	CbGeAlD
Aripiprazole—Feeling abnormal—Procarbazine—brain cancer	0.000328	0.000954	CcSEcCtD
Aripiprazole—Eye disorder—Carmustine—brain cancer	0.000327	0.000953	CcSEcCtD
Aripiprazole—Convulsion—Hydroxyurea—brain cancer	0.000327	0.000951	CcSEcCtD
Aripiprazole—Visual impairment—Temozolomide—brain cancer	0.000326	0.00095	CcSEcCtD
Aripiprazole—HTR7—central nervous system—brain cancer	0.000326	0.00118	CbGeAlD
Aripiprazole—CYP2D6—telencephalon—brain cancer	0.000326	0.00118	CbGeAlD
Aripiprazole—Gastrointestinal pain—Procarbazine—brain cancer	0.000325	0.000947	CcSEcCtD
Aripiprazole—Flushing—Carmustine—brain cancer	0.000325	0.000946	CcSEcCtD
Aripiprazole—HTR1D—brain—brain cancer	0.000325	0.00118	CbGeAlD
Aripiprazole—HTR2C—brain—brain cancer	0.000322	0.00117	CbGeAlD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000319	0.000928	CcSEcCtD
Aripiprazole—HTR7—cerebellum—brain cancer	0.000319	0.00115	CbGeAlD
Aripiprazole—Discomfort—Hydroxyurea—brain cancer	0.000317	0.000924	CcSEcCtD
Aripiprazole—Neutropenia—Etoposide—brain cancer	0.000316	0.000921	CcSEcCtD
Aripiprazole—Eye disorder—Temozolomide—brain cancer	0.000316	0.000921	CcSEcCtD
Aripiprazole—Urticaria—Procarbazine—brain cancer	0.000316	0.00092	CcSEcCtD
Aripiprazole—ADRB1—brain—brain cancer	0.000316	0.00114	CbGeAlD
Aripiprazole—Tinnitus—Temozolomide—brain cancer	0.000316	0.000919	CcSEcCtD
Aripiprazole—ADRA1A—central nervous system—brain cancer	0.000314	0.00114	CbGeAlD
Aripiprazole—Abdominal pain—Procarbazine—brain cancer	0.000314	0.000915	CcSEcCtD
Aripiprazole—Body temperature increased—Procarbazine—brain cancer	0.000314	0.000915	CcSEcCtD
Aripiprazole—Flushing—Temozolomide—brain cancer	0.000314	0.000915	CcSEcCtD
Aripiprazole—Cardiac disorder—Temozolomide—brain cancer	0.000314	0.000915	CcSEcCtD
Aripiprazole—Alopecia—Carmustine—brain cancer	0.000309	0.000901	CcSEcCtD
Aripiprazole—DRD2—central nervous system—brain cancer	0.000308	0.00112	CbGeAlD
Aripiprazole—Oedema—Hydroxyurea—brain cancer	0.000308	0.000896	CcSEcCtD
Aripiprazole—ADRA1A—cerebellum—brain cancer	0.000307	0.00111	CbGeAlD
Aripiprazole—Angiopathy—Temozolomide—brain cancer	0.000307	0.000894	CcSEcCtD
Aripiprazole—Mental disorder—Carmustine—brain cancer	0.000307	0.000893	CcSEcCtD
Aripiprazole—Infection—Hydroxyurea—brain cancer	0.000306	0.00089	CcSEcCtD
Aripiprazole—Immune system disorder—Temozolomide—brain cancer	0.000306	0.00089	CcSEcCtD
Aripiprazole—Mediastinal disorder—Temozolomide—brain cancer	0.000305	0.000888	CcSEcCtD
Aripiprazole—SLC6A4—brain—brain cancer	0.000305	0.0011	CbGeAlD
Aripiprazole—Erythema—Carmustine—brain cancer	0.000305	0.000888	CcSEcCtD
Aripiprazole—Malnutrition—Carmustine—brain cancer	0.000305	0.000888	CcSEcCtD
Aripiprazole—CHRM1—brain—brain cancer	0.000304	0.0011	CbGeAlD
Aripiprazole—Chills—Temozolomide—brain cancer	0.000304	0.000884	CcSEcCtD
Aripiprazole—KCNH2—central nervous system—brain cancer	0.000304	0.0011	CbGeAlD
Aripiprazole—Pneumonia—Etoposide—brain cancer	0.000303	0.000883	CcSEcCtD
Aripiprazole—HTR2B—brain—brain cancer	0.000302	0.00109	CbGeAlD
Aripiprazole—ADRA2A—midbrain—brain cancer	0.000302	0.00109	CbGeAlD
Aripiprazole—Nervous system disorder—Hydroxyurea—brain cancer	0.000302	0.000879	CcSEcCtD
Aripiprazole—Infestation—Etoposide—brain cancer	0.000302	0.000878	CcSEcCtD
Aripiprazole—Infestation NOS—Etoposide—brain cancer	0.000302	0.000878	CcSEcCtD
Aripiprazole—Thrombocytopenia—Hydroxyurea—brain cancer	0.000301	0.000877	CcSEcCtD
Aripiprazole—DRD2—cerebellum—brain cancer	0.000301	0.00109	CbGeAlD
Aripiprazole—ADRA2C—central nervous system—brain cancer	0.0003	0.00109	CbGeAlD
Aripiprazole—Alopecia—Temozolomide—brain cancer	0.000299	0.000871	CcSEcCtD
Aripiprazole—Skin disorder—Hydroxyurea—brain cancer	0.000299	0.00087	CcSEcCtD
Aripiprazole—HTR2A—gonad—brain cancer	0.000298	0.00108	CbGeAlD
Aripiprazole—Acute coronary syndrome—Etoposide—brain cancer	0.000297	0.000866	CcSEcCtD
Aripiprazole—KCNH2—cerebellum—brain cancer	0.000297	0.00108	CbGeAlD
Aripiprazole—Renal failure—Etoposide—brain cancer	0.000297	0.000863	CcSEcCtD
Aripiprazole—Mental disorder—Temozolomide—brain cancer	0.000296	0.000863	CcSEcCtD
Aripiprazole—Myocardial infarction—Etoposide—brain cancer	0.000296	0.000861	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Etoposide—brain cancer	0.000296	0.000861	CcSEcCtD
Aripiprazole—Back pain—Carmustine—brain cancer	0.000295	0.000859	CcSEcCtD
Aripiprazole—ADRA2A—spinal cord—brain cancer	0.000295	0.00107	CbGeAlD
Aripiprazole—Erythema—Temozolomide—brain cancer	0.000295	0.000858	CcSEcCtD
Aripiprazole—Malnutrition—Temozolomide—brain cancer	0.000295	0.000858	CcSEcCtD
Aripiprazole—Jaundice—Etoposide—brain cancer	0.000294	0.000856	CcSEcCtD
Aripiprazole—Stomatitis—Etoposide—brain cancer	0.000294	0.000856	CcSEcCtD
Aripiprazole—Anorexia—Hydroxyurea—brain cancer	0.000293	0.000854	CcSEcCtD
Aripiprazole—Hypersensitivity—Procarbazine—brain cancer	0.000293	0.000853	CcSEcCtD
Aripiprazole—ADRA2C—cerebellum—brain cancer	0.000293	0.00106	CbGeAlD
Aripiprazole—HTR2A—pituitary gland—brain cancer	0.000291	0.00105	CbGeAlD
Aripiprazole—Dysgeusia—Temozolomide—brain cancer	0.000288	0.00084	CcSEcCtD
Aripiprazole—Vision blurred—Carmustine—brain cancer	0.000287	0.000837	CcSEcCtD
Aripiprazole—Tremor—Carmustine—brain cancer	0.000286	0.000832	CcSEcCtD
Aripiprazole—Asthenia—Procarbazine—brain cancer	0.000285	0.000831	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Etoposide—brain cancer	0.000285	0.000831	CcSEcCtD
Aripiprazole—Back pain—Temozolomide—brain cancer	0.000285	0.00083	CcSEcCtD
Aripiprazole—Anaemia—Carmustine—brain cancer	0.000282	0.00082	CcSEcCtD
Aripiprazole—Agranulocytosis—Etoposide—brain cancer	0.000281	0.00082	CcSEcCtD
Aripiprazole—Pruritus—Procarbazine—brain cancer	0.000281	0.000819	CcSEcCtD
Aripiprazole—HTR2A—medulla oblongata—brain cancer	0.000281	0.00102	CbGeAlD
Aripiprazole—Agitation—Carmustine—brain cancer	0.00028	0.000816	CcSEcCtD
Aripiprazole—CYP3A5—endocrine gland—brain cancer	0.000278	0.00101	CbGeAlD
Aripiprazole—Vision blurred—Temozolomide—brain cancer	0.000278	0.000808	CcSEcCtD
Aripiprazole—Tremor—Temozolomide—brain cancer	0.000276	0.000804	CcSEcCtD
Aripiprazole—Dyspnoea—Hydroxyurea—brain cancer	0.000274	0.000799	CcSEcCtD
Aripiprazole—Somnolence—Hydroxyurea—brain cancer	0.000274	0.000797	CcSEcCtD
Aripiprazole—Ill-defined disorder—Temozolomide—brain cancer	0.000273	0.000796	CcSEcCtD
Aripiprazole—Leukopenia—Carmustine—brain cancer	0.000273	0.000795	CcSEcCtD
Aripiprazole—Anaemia—Temozolomide—brain cancer	0.000272	0.000793	CcSEcCtD
Aripiprazole—Diarrhoea—Procarbazine—brain cancer	0.000272	0.000792	CcSEcCtD
Aripiprazole—CHRM3—brain—brain cancer	0.000272	0.000985	CbGeAlD
Aripiprazole—Dyspepsia—Hydroxyurea—brain cancer	0.000271	0.000789	CcSEcCtD
Aripiprazole—HTR1A—brain—brain cancer	0.000271	0.000981	CbGeAlD
Aripiprazole—Agitation—Temozolomide—brain cancer	0.000271	0.000788	CcSEcCtD
Aripiprazole—HRH1—endocrine gland—brain cancer	0.00027	0.000978	CbGeAlD
Aripiprazole—Hypoaesthesia—Etoposide—brain cancer	0.000269	0.000785	CcSEcCtD
Aripiprazole—Angioedema—Temozolomide—brain cancer	0.000269	0.000784	CcSEcCtD
Aripiprazole—Decreased appetite—Hydroxyurea—brain cancer	0.000268	0.000779	CcSEcCtD
Aripiprazole—Urinary tract disorder—Etoposide—brain cancer	0.000267	0.000779	CcSEcCtD
Aripiprazole—HRH1—head—brain cancer	0.000267	0.000966	CbGeAlD
Aripiprazole—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000266	0.000774	CcSEcCtD
Aripiprazole—Malaise—Temozolomide—brain cancer	0.000266	0.000774	CcSEcCtD
Aripiprazole—Urethral disorder—Etoposide—brain cancer	0.000265	0.000773	CcSEcCtD
Aripiprazole—Fatigue—Hydroxyurea—brain cancer	0.000265	0.000773	CcSEcCtD
Aripiprazole—ADRA2A—endocrine gland—brain cancer	0.000265	0.000961	CbGeAlD
Aripiprazole—Vertigo—Temozolomide—brain cancer	0.000265	0.000771	CcSEcCtD
Aripiprazole—Convulsion—Carmustine—brain cancer	0.000264	0.000769	CcSEcCtD
Aripiprazole—Leukopenia—Temozolomide—brain cancer	0.000264	0.000768	CcSEcCtD
Aripiprazole—Hypertension—Carmustine—brain cancer	0.000263	0.000766	CcSEcCtD
Aripiprazole—Pain—Hydroxyurea—brain cancer	0.000263	0.000766	CcSEcCtD
Aripiprazole—Constipation—Hydroxyurea—brain cancer	0.000263	0.000766	CcSEcCtD
Aripiprazole—Dizziness—Procarbazine—brain cancer	0.000263	0.000766	CcSEcCtD
Aripiprazole—ADRA2A—head—brain cancer	0.000262	0.000949	CbGeAlD
Aripiprazole—Palpitations—Temozolomide—brain cancer	0.00026	0.000758	CcSEcCtD
Aripiprazole—Chest pain—Carmustine—brain cancer	0.00026	0.000756	CcSEcCtD
Aripiprazole—Myalgia—Carmustine—brain cancer	0.00026	0.000756	CcSEcCtD
Aripiprazole—HTR7—brain—brain cancer	0.000259	0.000937	CbGeAlD
Aripiprazole—Anxiety—Carmustine—brain cancer	0.000259	0.000753	CcSEcCtD
Aripiprazole—Cough—Temozolomide—brain cancer	0.000257	0.000749	CcSEcCtD
Aripiprazole—HTR2A—midbrain—brain cancer	0.000257	0.00093	CbGeAlD
Aripiprazole—Convulsion—Temozolomide—brain cancer	0.000255	0.000743	CcSEcCtD
Aripiprazole—Hypertension—Temozolomide—brain cancer	0.000254	0.000741	CcSEcCtD
Aripiprazole—Feeling abnormal—Hydroxyurea—brain cancer	0.000254	0.000739	CcSEcCtD
Aripiprazole—Eye disorder—Etoposide—brain cancer	0.000253	0.000737	CcSEcCtD
Aripiprazole—Vomiting—Procarbazine—brain cancer	0.000253	0.000736	CcSEcCtD
Aripiprazole—Cardiac disorder—Etoposide—brain cancer	0.000251	0.000732	CcSEcCtD
Aripiprazole—Flushing—Etoposide—brain cancer	0.000251	0.000732	CcSEcCtD
Aripiprazole—Confusional state—Carmustine—brain cancer	0.000251	0.00073	CcSEcCtD
Aripiprazole—Arthralgia—Temozolomide—brain cancer	0.000251	0.00073	CcSEcCtD
Aripiprazole—Myalgia—Temozolomide—brain cancer	0.000251	0.00073	CcSEcCtD
Aripiprazole—Rash—Procarbazine—brain cancer	0.000251	0.00073	CcSEcCtD
Aripiprazole—HTR2A—spinal cord—brain cancer	0.000251	0.000908	CbGeAlD
Aripiprazole—Dermatitis—Procarbazine—brain cancer	0.00025	0.000729	CcSEcCtD
Aripiprazole—Anxiety—Temozolomide—brain cancer	0.00025	0.000728	CcSEcCtD
Aripiprazole—ADRA1A—brain—brain cancer	0.00025	0.000904	CbGeAlD
Aripiprazole—Headache—Procarbazine—brain cancer	0.000249	0.000725	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000249	0.000725	CcSEcCtD
Aripiprazole—Oedema—Carmustine—brain cancer	0.000249	0.000724	CcSEcCtD
Aripiprazole—Discomfort—Temozolomide—brain cancer	0.000248	0.000722	CcSEcCtD
Aripiprazole—Infection—Carmustine—brain cancer	0.000247	0.00072	CcSEcCtD
Aripiprazole—Angiopathy—Etoposide—brain cancer	0.000246	0.000715	CcSEcCtD
Aripiprazole—Dry mouth—Temozolomide—brain cancer	0.000245	0.000714	CcSEcCtD
Aripiprazole—DRD2—brain—brain cancer	0.000245	0.000886	CbGeAlD
Aripiprazole—Immune system disorder—Etoposide—brain cancer	0.000245	0.000712	CcSEcCtD
Aripiprazole—Mediastinal disorder—Etoposide—brain cancer	0.000244	0.000711	CcSEcCtD
Aripiprazole—Thrombocytopenia—Carmustine—brain cancer	0.000244	0.000709	CcSEcCtD
Aripiprazole—HRH1—central nervous system—brain cancer	0.000243	0.000882	CbGeAlD
Aripiprazole—Body temperature increased—Hydroxyurea—brain cancer	0.000243	0.000708	CcSEcCtD
Aripiprazole—Chills—Etoposide—brain cancer	0.000243	0.000708	CcSEcCtD
Aripiprazole—Tachycardia—Carmustine—brain cancer	0.000243	0.000707	CcSEcCtD
Aripiprazole—Confusional state—Temozolomide—brain cancer	0.000242	0.000706	CcSEcCtD
Aripiprazole—KCNH2—brain—brain cancer	0.000241	0.000873	CbGeAlD
Aripiprazole—Oedema—Temozolomide—brain cancer	0.00024	0.0007	CcSEcCtD
Aripiprazole—Anaphylactic shock—Temozolomide—brain cancer	0.00024	0.0007	CcSEcCtD
Aripiprazole—Alopecia—Etoposide—brain cancer	0.000239	0.000697	CcSEcCtD
Aripiprazole—ADRA2A—central nervous system—brain cancer	0.000239	0.000866	CbGeAlD
Aripiprazole—Infection—Temozolomide—brain cancer	0.000239	0.000696	CcSEcCtD
Aripiprazole—ADRA2C—brain—brain cancer	0.000238	0.000862	CbGeAlD
Aripiprazole—Anorexia—Carmustine—brain cancer	0.000237	0.000691	CcSEcCtD
Aripiprazole—Nausea—Procarbazine—brain cancer	0.000236	0.000688	CcSEcCtD
Aripiprazole—Nervous system disorder—Temozolomide—brain cancer	0.000236	0.000687	CcSEcCtD
Aripiprazole—Thrombocytopenia—Temozolomide—brain cancer	0.000235	0.000685	CcSEcCtD
Aripiprazole—ABCB1—telencephalon—brain cancer	0.000234	0.000849	CbGeAlD
Aripiprazole—ADRA2A—cerebellum—brain cancer	0.000234	0.000846	CbGeAlD
Aripiprazole—Skin disorder—Temozolomide—brain cancer	0.000234	0.00068	CcSEcCtD
Aripiprazole—Hypotension—Carmustine—brain cancer	0.000232	0.000677	CcSEcCtD
Aripiprazole—Hyperhidrosis—Temozolomide—brain cancer	0.000232	0.000677	CcSEcCtD
Aripiprazole—Dysgeusia—Etoposide—brain cancer	0.000231	0.000672	CcSEcCtD
Aripiprazole—Anorexia—Temozolomide—brain cancer	0.000229	0.000667	CcSEcCtD
Aripiprazole—Back pain—Etoposide—brain cancer	0.000228	0.000664	CcSEcCtD
Aripiprazole—Hypersensitivity—Hydroxyurea—brain cancer	0.000227	0.00066	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Carmustine—brain cancer	0.000227	0.00066	CcSEcCtD
Aripiprazole—Muscle spasms—Etoposide—brain cancer	0.000227	0.00066	CcSEcCtD
Aripiprazole—HTR2A—endocrine gland—brain cancer	0.000226	0.000817	CbGeAlD
Aripiprazole—Insomnia—Carmustine—brain cancer	0.000225	0.000655	CcSEcCtD
Aripiprazole—Paraesthesia—Carmustine—brain cancer	0.000223	0.000651	CcSEcCtD
Aripiprazole—HTR2A—head—brain cancer	0.000223	0.000807	CbGeAlD
Aripiprazole—Dyspnoea—Carmustine—brain cancer	0.000222	0.000646	CcSEcCtD
Aripiprazole—Somnolence—Carmustine—brain cancer	0.000221	0.000644	CcSEcCtD
Aripiprazole—Asthenia—Hydroxyurea—brain cancer	0.000221	0.000643	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000219	0.000638	CcSEcCtD
Aripiprazole—Ill-defined disorder—Etoposide—brain cancer	0.000219	0.000637	CcSEcCtD
Aripiprazole—Anaemia—Etoposide—brain cancer	0.000218	0.000634	CcSEcCtD
Aripiprazole—Insomnia—Temozolomide—brain cancer	0.000217	0.000633	CcSEcCtD
Aripiprazole—Decreased appetite—Carmustine—brain cancer	0.000216	0.00063	CcSEcCtD
Aripiprazole—Paraesthesia—Temozolomide—brain cancer	0.000216	0.000629	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Carmustine—brain cancer	0.000215	0.000625	CcSEcCtD
Aripiprazole—Dyspnoea—Temozolomide—brain cancer	0.000214	0.000624	CcSEcCtD
Aripiprazole—Somnolence—Temozolomide—brain cancer	0.000214	0.000622	CcSEcCtD
Aripiprazole—Pain—Carmustine—brain cancer	0.000213	0.00062	CcSEcCtD
Aripiprazole—Constipation—Carmustine—brain cancer	0.000213	0.00062	CcSEcCtD
Aripiprazole—Malaise—Etoposide—brain cancer	0.000213	0.000619	CcSEcCtD
Aripiprazole—Vertigo—Etoposide—brain cancer	0.000212	0.000617	CcSEcCtD
Aripiprazole—Dyspepsia—Temozolomide—brain cancer	0.000212	0.000616	CcSEcCtD
Aripiprazole—Leukopenia—Etoposide—brain cancer	0.000211	0.000614	CcSEcCtD
Aripiprazole—Diarrhoea—Hydroxyurea—brain cancer	0.000211	0.000613	CcSEcCtD
Aripiprazole—Decreased appetite—Temozolomide—brain cancer	0.000209	0.000609	CcSEcCtD
Aripiprazole—CYP3A4—endocrine gland—brain cancer	0.000209	0.000756	CbGeAlD
Aripiprazole—Gastrointestinal disorder—Temozolomide—brain cancer	0.000208	0.000604	CcSEcCtD
Aripiprazole—Fatigue—Temozolomide—brain cancer	0.000207	0.000604	CcSEcCtD
Aripiprazole—Loss of consciousness—Etoposide—brain cancer	0.000207	0.000603	CcSEcCtD
Aripiprazole—Cough—Etoposide—brain cancer	0.000206	0.000599	CcSEcCtD
Aripiprazole—Pain—Temozolomide—brain cancer	0.000206	0.000599	CcSEcCtD
Aripiprazole—Constipation—Temozolomide—brain cancer	0.000206	0.000599	CcSEcCtD
Aripiprazole—CYP2D6—endocrine gland—brain cancer	0.000205	0.000744	CbGeAlD
Aripiprazole—Feeling abnormal—Carmustine—brain cancer	0.000205	0.000597	CcSEcCtD
Aripiprazole—Convulsion—Etoposide—brain cancer	0.000204	0.000595	CcSEcCtD
Aripiprazole—Hypertension—Etoposide—brain cancer	0.000204	0.000593	CcSEcCtD
Aripiprazole—Dizziness—Hydroxyurea—brain cancer	0.000204	0.000593	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Carmustine—brain cancer	0.000203	0.000592	CcSEcCtD
Aripiprazole—HTR2A—central nervous system—brain cancer	0.000203	0.000736	CbGeAlD
Aripiprazole—CYP2D6—head—brain cancer	0.000203	0.000735	CbGeAlD
Aripiprazole—Chest pain—Etoposide—brain cancer	0.000201	0.000584	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000199	0.00058	CcSEcCtD
Aripiprazole—HTR2A—cerebellum—brain cancer	0.000199	0.00072	CbGeAlD
Aripiprazole—Discomfort—Etoposide—brain cancer	0.000198	0.000577	CcSEcCtD
Aripiprazole—Feeling abnormal—Temozolomide—brain cancer	0.000198	0.000577	CcSEcCtD
Aripiprazole—Body temperature increased—Carmustine—brain cancer	0.000197	0.000573	CcSEcCtD
Aripiprazole—Abdominal pain—Carmustine—brain cancer	0.000197	0.000573	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Temozolomide—brain cancer	0.000197	0.000572	CcSEcCtD
Aripiprazole—Vomiting—Hydroxyurea—brain cancer	0.000196	0.00057	CcSEcCtD
Aripiprazole—ABCB1—gonad—brain cancer	0.000196	0.000708	CbGeAlD
Aripiprazole—Rash—Hydroxyurea—brain cancer	0.000194	0.000565	CcSEcCtD
Aripiprazole—Confusional state—Etoposide—brain cancer	0.000194	0.000565	CcSEcCtD
Aripiprazole—Dermatitis—Hydroxyurea—brain cancer	0.000194	0.000565	CcSEcCtD
Aripiprazole—HRH1—brain—brain cancer	0.000193	0.0007	CbGeAlD
Aripiprazole—Headache—Hydroxyurea—brain cancer	0.000193	0.000561	CcSEcCtD
Aripiprazole—Anaphylactic shock—Etoposide—brain cancer	0.000192	0.00056	CcSEcCtD
Aripiprazole—Infection—Etoposide—brain cancer	0.000191	0.000557	CcSEcCtD
Aripiprazole—Urticaria—Temozolomide—brain cancer	0.000191	0.000556	CcSEcCtD
Aripiprazole—ABCB1—pituitary gland—brain cancer	0.000191	0.000691	CbGeAlD
Aripiprazole—Body temperature increased—Temozolomide—brain cancer	0.00019	0.000553	CcSEcCtD
Aripiprazole—Abdominal pain—Temozolomide—brain cancer	0.00019	0.000553	CcSEcCtD
Aripiprazole—ADRA2A—brain—brain cancer	0.00019	0.000687	CbGeAlD
Aripiprazole—Thrombocytopenia—Etoposide—brain cancer	0.000188	0.000549	CcSEcCtD
Aripiprazole—CYP3A4—central nervous system—brain cancer	0.000188	0.000682	CbGeAlD
Aripiprazole—Tachycardia—Etoposide—brain cancer	0.000188	0.000547	CcSEcCtD
Aripiprazole—Skin disorder—Etoposide—brain cancer	0.000187	0.000544	CcSEcCtD
Aripiprazole—Hyperhidrosis—Etoposide—brain cancer	0.000186	0.000542	CcSEcCtD
Aripiprazole—CYP2D6—central nervous system—brain cancer	0.000185	0.000671	CbGeAlD
Aripiprazole—ABCB1—medulla oblongata—brain cancer	0.000184	0.000667	CbGeAlD
Aripiprazole—Anorexia—Etoposide—brain cancer	0.000183	0.000534	CcSEcCtD
Aripiprazole—Hypersensitivity—Carmustine—brain cancer	0.000183	0.000534	CcSEcCtD
Aripiprazole—Nausea—Hydroxyurea—brain cancer	0.000183	0.000532	CcSEcCtD
Aripiprazole—CYP2D6—cerebellum—brain cancer	0.000181	0.000656	CbGeAlD
Aripiprazole—Hypotension—Etoposide—brain cancer	0.00018	0.000523	CcSEcCtD
Aripiprazole—Asthenia—Carmustine—brain cancer	0.000178	0.00052	CcSEcCtD
Aripiprazole—Hypersensitivity—Temozolomide—brain cancer	0.000177	0.000516	CcSEcCtD
Aripiprazole—Paraesthesia—Etoposide—brain cancer	0.000173	0.000503	CcSEcCtD
Aripiprazole—Asthenia—Temozolomide—brain cancer	0.000172	0.000502	CcSEcCtD
Aripiprazole—Dyspnoea—Etoposide—brain cancer	0.000172	0.000499	CcSEcCtD
Aripiprazole—Somnolence—Etoposide—brain cancer	0.000171	0.000498	CcSEcCtD
Aripiprazole—Diarrhoea—Carmustine—brain cancer	0.00017	0.000496	CcSEcCtD
Aripiprazole—Pruritus—Temozolomide—brain cancer	0.00017	0.000495	CcSEcCtD
Aripiprazole—ABCB1—midbrain—brain cancer	0.000168	0.00061	CbGeAlD
Aripiprazole—Decreased appetite—Etoposide—brain cancer	0.000167	0.000487	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Etoposide—brain cancer	0.000166	0.000484	CcSEcCtD
Aripiprazole—Fatigue—Etoposide—brain cancer	0.000166	0.000483	CcSEcCtD
Aripiprazole—Dizziness—Carmustine—brain cancer	0.000165	0.000479	CcSEcCtD
Aripiprazole—Pain—Etoposide—brain cancer	0.000165	0.000479	CcSEcCtD
Aripiprazole—Constipation—Etoposide—brain cancer	0.000165	0.000479	CcSEcCtD
Aripiprazole—Diarrhoea—Temozolomide—brain cancer	0.000164	0.000479	CcSEcCtD
Aripiprazole—ABCB1—spinal cord—brain cancer	0.000164	0.000595	CbGeAlD
Aripiprazole—HTR2A—brain—brain cancer	0.000161	0.000585	CbGeAlD
Aripiprazole—Dizziness—Temozolomide—brain cancer	0.000159	0.000463	CcSEcCtD
Aripiprazole—Feeling abnormal—Etoposide—brain cancer	0.000159	0.000462	CcSEcCtD
Aripiprazole—Vomiting—Carmustine—brain cancer	0.000158	0.000461	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Etoposide—brain cancer	0.000157	0.000458	CcSEcCtD
Aripiprazole—Rash—Carmustine—brain cancer	0.000157	0.000457	CcSEcCtD
Aripiprazole—Dermatitis—Carmustine—brain cancer	0.000157	0.000456	CcSEcCtD
Aripiprazole—Headache—Carmustine—brain cancer	0.000156	0.000454	CcSEcCtD
Aripiprazole—Vomiting—Temozolomide—brain cancer	0.000153	0.000445	CcSEcCtD
Aripiprazole—Urticaria—Etoposide—brain cancer	0.000153	0.000445	CcSEcCtD
Aripiprazole—Abdominal pain—Etoposide—brain cancer	0.000152	0.000443	CcSEcCtD
Aripiprazole—Body temperature increased—Etoposide—brain cancer	0.000152	0.000443	CcSEcCtD
Aripiprazole—Rash—Temozolomide—brain cancer	0.000152	0.000441	CcSEcCtD
Aripiprazole—Dermatitis—Temozolomide—brain cancer	0.000151	0.000441	CcSEcCtD
Aripiprazole—Headache—Temozolomide—brain cancer	0.000151	0.000439	CcSEcCtD
Aripiprazole—ABCB1—endocrine gland—brain cancer	0.000148	0.000535	CbGeAlD
Aripiprazole—Nausea—Carmustine—brain cancer	0.000148	0.00043	CcSEcCtD
Aripiprazole—CYP2D6—brain—brain cancer	0.000147	0.000532	CbGeAlD
Aripiprazole—ABCB1—head—brain cancer	0.000146	0.000529	CbGeAlD
Aripiprazole—Nausea—Temozolomide—brain cancer	0.000143	0.000416	CcSEcCtD
Aripiprazole—Hypersensitivity—Etoposide—brain cancer	0.000142	0.000413	CcSEcCtD
Aripiprazole—Asthenia—Etoposide—brain cancer	0.000138	0.000402	CcSEcCtD
Aripiprazole—Pruritus—Etoposide—brain cancer	0.000136	0.000396	CcSEcCtD
Aripiprazole—ABCB1—central nervous system—brain cancer	0.000133	0.000482	CbGeAlD
Aripiprazole—Diarrhoea—Etoposide—brain cancer	0.000132	0.000383	CcSEcCtD
Aripiprazole—ABCB1—cerebellum—brain cancer	0.00013	0.000472	CbGeAlD
Aripiprazole—Dizziness—Etoposide—brain cancer	0.000127	0.00037	CcSEcCtD
Aripiprazole—Vomiting—Etoposide—brain cancer	0.000122	0.000356	CcSEcCtD
Aripiprazole—Rash—Etoposide—brain cancer	0.000121	0.000353	CcSEcCtD
Aripiprazole—Dermatitis—Etoposide—brain cancer	0.000121	0.000353	CcSEcCtD
Aripiprazole—Headache—Etoposide—brain cancer	0.000121	0.000351	CcSEcCtD
Aripiprazole—Nausea—Etoposide—brain cancer	0.000114	0.000333	CcSEcCtD
Aripiprazole—ABCB1—brain—brain cancer	0.000106	0.000383	CbGeAlD
Aripiprazole—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.06e-05	7.58e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL2—brain cancer	1.06e-05	7.57e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—RELA—brain cancer	1.06e-05	7.56e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.05e-05	7.55e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—ERBB2—brain cancer	1.05e-05	7.52e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CCND1—brain cancer	1.05e-05	7.5e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL2—brain cancer	1.04e-05	7.47e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—RELA—brain cancer	1.04e-05	7.46e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—TP53—brain cancer	1.04e-05	7.44e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.04e-05	7.42e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—ERBB2—brain cancer	1.04e-05	7.42e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.03e-05	7.41e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CCND1—brain cancer	1.03e-05	7.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.02e-05	7.34e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—APC—brain cancer	1.02e-05	7.31e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	7.31e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CTNNB1—brain cancer	1.02e-05	7.31e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CCND1—brain cancer	1.02e-05	7.28e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ENO2—brain cancer	1.01e-05	7.27e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL2—brain cancer	1.01e-05	7.22e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.01e-05	7.22e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CTNNB1—brain cancer	1.01e-05	7.21e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—APC—brain cancer	1e-05	7.19e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1e-05	7.19e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—APC—brain cancer	1e-05	7.18e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PIK3CG—brain cancer	1e-05	7.18e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PIK3CG—brain cancer	1e-05	7.17e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CG—brain cancer	9.98e-06	7.15e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—APC—brain cancer	9.98e-06	7.15e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL2—brain cancer	9.98e-06	7.15e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—APC—brain cancer	9.95e-06	7.13e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CG—brain cancer	9.95e-06	7.13e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CG—brain cancer	9.86e-06	7.06e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—APC—brain cancer	9.86e-06	7.06e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CCND1—brain cancer	9.83e-06	7.04e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—APC—brain cancer	9.83e-06	7.04e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	9.83e-06	7.04e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CTNNB1—brain cancer	9.73e-06	6.97e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CCND1—brain cancer	9.73e-06	6.97e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CTNNB1—brain cancer	9.63e-06	6.9e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL2—brain cancer	9.51e-06	6.81e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—RELA—brain cancer	9.49e-06	6.8e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—ERBB2—brain cancer	9.43e-06	6.76e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—RELA—brain cancer	9.4e-06	6.74e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—VEGFA—brain cancer	9.39e-06	6.73e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL2—brain cancer	9.38e-06	6.72e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—VEGFA—brain cancer	9.38e-06	6.72e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—ERBB2—brain cancer	9.35e-06	6.7e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—VEGFA—brain cancer	9.32e-06	6.68e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—STAT3—brain cancer	9.29e-06	6.66e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—EGFR—brain cancer	9.29e-06	6.66e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—STAT3—brain cancer	9.28e-06	6.65e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CCND1—brain cancer	9.27e-06	6.64e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—STAT3—brain cancer	9.22e-06	6.61e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—TP53—brain cancer	9.19e-06	6.58e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CTNNB1—brain cancer	9.18e-06	6.58e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CCND1—brain cancer	9.15e-06	6.55e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—EGFR—brain cancer	9.14e-06	6.55e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	9.13e-06	6.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—APC—brain cancer	9.13e-06	6.54e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—EGFR—brain cancer	9.12e-06	6.54e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—VEGFA—brain cancer	9.12e-06	6.54e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—EGFR—brain cancer	9.1e-06	6.52e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—RELA—brain cancer	9.08e-06	6.51e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—EGFR—brain cancer	9.07e-06	6.5e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CTNNB1—brain cancer	9.06e-06	6.49e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—STAT3—brain cancer	9.03e-06	6.47e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—RELA—brain cancer	9.03e-06	6.47e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—ERBB2—brain cancer	9.02e-06	6.46e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—EGFR—brain cancer	8.98e-06	6.43e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—VEGFA—brain cancer	8.98e-06	6.43e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—ERBB2—brain cancer	8.97e-06	6.43e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—EGFR—brain cancer	8.95e-06	6.42e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—STAT3—brain cancer	8.89e-06	6.37e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—VEGFA—brain cancer	8.85e-06	6.35e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—RELA—brain cancer	8.78e-06	6.29e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—STAT3—brain cancer	8.77e-06	6.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—ERBB2—brain cancer	8.73e-06	6.26e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—RELA—brain cancer	8.65e-06	6.2e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MYC—brain cancer	8.64e-06	6.19e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MYC—brain cancer	8.63e-06	6.18e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—ERBB2—brain cancer	8.59e-06	6.16e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MYC—brain cancer	8.57e-06	6.14e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—VEGFA—brain cancer	8.57e-06	6.14e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL2—brain cancer	8.55e-06	6.12e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—STAT3—brain cancer	8.48e-06	6.08e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—VEGFA—brain cancer	8.48e-06	6.08e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL2—brain cancer	8.47e-06	6.07e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—EGFR—brain cancer	8.45e-06	6.05e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—EGFR—brain cancer	8.44e-06	6.05e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—STAT3—brain cancer	8.4e-06	6.02e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MYC—brain cancer	8.39e-06	6.01e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—EGFR—brain cancer	8.38e-06	6.01e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CCND1—brain cancer	8.33e-06	5.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—EGFR—brain cancer	8.32e-06	5.96e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MYC—brain cancer	8.26e-06	5.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CCND1—brain cancer	8.26e-06	5.92e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CTNNB1—brain cancer	8.25e-06	5.91e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—EGFR—brain cancer	8.21e-06	5.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	8.18e-06	5.86e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL2—brain cancer	8.18e-06	5.86e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MYC—brain cancer	8.15e-06	5.84e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL2—brain cancer	8.13e-06	5.83e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—brain cancer	8.08e-06	5.79e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—EGFR—brain cancer	8.08e-06	5.79e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—STAT3—brain cancer	8e-06	5.73e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—brain cancer	7.97e-06	5.71e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—RELA—brain cancer	7.97e-06	5.71e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CCND1—brain cancer	7.97e-06	5.71e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—EGFR—brain cancer	7.97e-06	5.71e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CCND1—brain cancer	7.93e-06	5.68e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—ERBB2—brain cancer	7.92e-06	5.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL2—brain cancer	7.91e-06	5.67e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—STAT3—brain cancer	7.89e-06	5.66e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CTNNB1—brain cancer	7.89e-06	5.66e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MYC—brain cancer	7.88e-06	5.65e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CTNNB1—brain cancer	7.85e-06	5.63e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—RELA—brain cancer	7.84e-06	5.62e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—RELA—brain cancer	7.83e-06	5.61e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MYC—brain cancer	7.8e-06	5.59e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—RELA—brain cancer	7.8e-06	5.59e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—ERBB2—brain cancer	7.79e-06	5.58e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL2—brain cancer	7.79e-06	5.58e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—ERBB2—brain cancer	7.78e-06	5.57e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—RELA—brain cancer	7.78e-06	5.57e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—ERBB2—brain cancer	7.75e-06	5.55e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—ERBB2—brain cancer	7.73e-06	5.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CCND1—brain cancer	7.71e-06	5.53e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—EGFR—brain cancer	7.71e-06	5.53e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—RELA—brain cancer	7.7e-06	5.52e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—RELA—brain cancer	7.68e-06	5.5e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—ERBB2—brain cancer	7.65e-06	5.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	7.64e-06	5.47e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—EGFR—brain cancer	7.63e-06	5.47e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—ERBB2—brain cancer	7.63e-06	5.47e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CCND1—brain cancer	7.59e-06	5.44e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CG—brain cancer	7.55e-06	5.41e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	7.52e-06	5.39e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MYC—brain cancer	7.43e-06	5.33e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MYC—brain cancer	7.34e-06	5.26e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EGFR—brain cancer	7.27e-06	5.21e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—brain cancer	7.26e-06	5.21e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—brain cancer	7.2e-06	5.16e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—STAT3—brain cancer	7.19e-06	5.15e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—brain cancer	7.18e-06	5.14e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EGFR—brain cancer	7.17e-06	5.14e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—RELA—brain cancer	7.14e-06	5.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—STAT3—brain cancer	7.13e-06	5.11e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CG—brain cancer	7.12e-06	5.1e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—brain cancer	7.09e-06	5.08e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—ERBB2—brain cancer	7.09e-06	5.08e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—brain cancer	7.08e-06	5.08e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—brain cancer	7.06e-06	5.06e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—brain cancer	7.05e-06	5.05e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—brain cancer	7.04e-06	5.04e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—brain cancer	7.03e-06	5.03e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—brain cancer	7e-06	5.02e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCND1—brain cancer	7e-06	5.01e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—brain cancer	6.95e-06	4.98e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—brain cancer	6.94e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CTNNB1—brain cancer	6.93e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—brain cancer	6.92e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—brain cancer	6.91e-06	4.95e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—brain cancer	6.89e-06	4.94e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCND1—brain cancer	6.89e-06	4.93e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—STAT3—brain cancer	6.88e-06	4.93e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCND1—brain cancer	6.87e-06	4.92e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCND1—brain cancer	6.85e-06	4.91e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—STAT3—brain cancer	6.84e-06	4.9e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCND1—brain cancer	6.83e-06	4.89e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CTNNB1—brain cancer	6.82e-06	4.89e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CTNNB1—brain cancer	6.8e-06	4.88e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CTNNB1—brain cancer	6.78e-06	4.86e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—brain cancer	6.78e-06	4.86e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CTNNB1—brain cancer	6.76e-06	4.84e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCND1—brain cancer	6.76e-06	4.84e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCND1—brain cancer	6.74e-06	4.83e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—brain cancer	6.72e-06	4.82e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CTNNB1—brain cancer	6.69e-06	4.8e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—brain cancer	6.69e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MYC—brain cancer	6.68e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	6.68e-06	4.78e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—STAT3—brain cancer	6.66e-06	4.77e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MYC—brain cancer	6.62e-06	4.75e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—brain cancer	6.62e-06	4.74e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—STAT3—brain cancer	6.55e-06	4.69e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—brain cancer	6.54e-06	4.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—brain cancer	6.48e-06	4.64e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—brain cancer	6.47e-06	4.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—brain cancer	6.43e-06	4.6e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—brain cancer	6.41e-06	4.59e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—brain cancer	6.39e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—brain cancer	6.36e-06	4.56e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCND1—brain cancer	6.26e-06	4.49e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—brain cancer	6.25e-06	4.48e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—brain cancer	6.22e-06	4.46e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	6.2e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—brain cancer	6.19e-06	4.43e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—brain cancer	6.11e-06	4.37e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—brain cancer	6.1e-06	4.37e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—brain cancer	6.09e-06	4.36e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—brain cancer	6.05e-06	4.34e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—brain cancer	6.04e-06	4.33e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—brain cancer	6.02e-06	4.32e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—brain cancer	6e-06	4.3e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—brain cancer	5.99e-06	4.29e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—brain cancer	5.97e-06	4.28e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—brain cancer	5.95e-06	4.27e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—brain cancer	5.95e-06	4.26e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—brain cancer	5.94e-06	4.26e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—brain cancer	5.93e-06	4.25e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—brain cancer	5.91e-06	4.24e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—brain cancer	5.89e-06	4.22e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—brain cancer	5.89e-06	4.22e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—brain cancer	5.88e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—brain cancer	5.84e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—brain cancer	5.82e-06	4.17e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—brain cancer	5.61e-06	4.02e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—brain cancer	5.52e-06	3.96e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—brain cancer	5.51e-06	3.95e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—brain cancer	5.49e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—brain cancer	5.49e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—brain cancer	5.49e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—brain cancer	5.48e-06	3.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—brain cancer	5.46e-06	3.91e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—brain cancer	5.44e-06	3.9e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—brain cancer	5.42e-06	3.89e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—brain cancer	5.41e-06	3.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—brain cancer	5.41e-06	3.87e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—brain cancer	5.4e-06	3.87e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—brain cancer	5.39e-06	3.86e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—brain cancer	5.37e-06	3.85e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—brain cancer	5.36e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—brain cancer	5.3e-06	3.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.29e-06	3.79e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—brain cancer	5.25e-06	3.76e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—brain cancer	5.22e-06	3.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—brain cancer	5.08e-06	3.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—brain cancer	5.02e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—brain cancer	5e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—brain cancer	4.91e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CG—brain cancer	4.65e-06	3.33e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—brain cancer	4.61e-06	3.3e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—brain cancer	4.54e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—brain cancer	4.53e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—brain cancer	4.51e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—brain cancer	4.5e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—brain cancer	4.45e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—brain cancer	4.44e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—brain cancer	4.13e-06	2.96e-05	CbGpPWpGaD
